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Schistosomes control inflammation in their hosts via highly effective mechanisms such
as induction of Tregs, Bregs, and alternatively activated macrophages (AAMs). Notably,
IPSE/alpha-1, the major secretory product from Schistosoma mansoni eggs, triggers
basophils to release interleukin (IL)-4 and IL-13. Both cytokines are essential for AAM
induction, suggesting an important role for IPSE/alpha-1 in inflammation control. Here,
we show by in vitro co-culture experiments that IPSE/alpha-1-induced basophil IL-4/IL-
13 inhibited pro-inflammatory cytokine release from human LPS-activated monocytes.
This effect was cell/cell contact-independent but dependent on IL-4, since it was
abrogated in the presence of anti-IL-4 antibodies. Importantly, the IPSE/alpha-1-
induced IL-4/IL-13 release from basophils was amplified in the presence of LPS.
Moreover, monocytes co-cultured in the presence of LPS with IPSE/alpha-1-stimulated
basophils adopted an AAM-like phenotype as assessed by elevated expression of
CD206 and CD209. The putative in vivo relevance of these findings was supported
by immunohistological staining of S. mansoni-infected murine tissue revealing close
physical contact between IPSE/alpha-1 and basophils in schistosome egg granulomas.
Taken together, we found that IPSE/alpha-1 dampens inflammatory cytokine responses
by triggering basophil IL-4/IL-13, in particular in the context of TLR activation, thereby
turning inflammatory monocytes into anti-inflammatory AAMs. This might represent a
mechanism used by schistosomes to control inflammation in the host.
Keywords: Schistosoma mansoni, IPSE/alpha-1, inflammation, basophils, Interleukin-4, Interleukin-13,
alternatively activated macrophages, Toll-like receptor
INTRODUCTION
Helminths have strong modulatory effects on the immune system of their hosts (1). For example,
epidemiological studies and animal experiments have shown that helminth infections can protect
against asthma, allergies and autoimmune diseases (2). In particular, the trematode Schistosoma
mansoni is a potent immunoregulator. Each schistosome couple produces approximately 300 eggs
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per day, which are laid in the mesenteric veins. About 50% of
the eggs are carried away with the blood stream and embolize
in the liver, where they induce granulomatous inflammation.
The other 50% migrate from the blood vessels through the
intestinal tissue toward the gut lumen. In the process they
induce mucosal granulomatous inflammation, leaving behind
phlegmonous migration channels (3, 4). The inflammation
permits egg egress, maintaining the life cycle of the parasite
(5, 6). However, the perforation channels enable bacteria to
enter the gut wall. Given the high number of eggs (and
consequent perforation channels), one would expect extensive
intestinal inflammation (and subsequent symptoms) in infected
individuals. However, most infected individuals develop only
moderate intestinal symptoms, such as intermittent abdominal
pain and diarrhea (3), suggesting that inflammation is kept
tightly under control. Experiments with S. mansoni-infected
mice revealed that IL-4 and intact IL-4 receptor signaling is
essential for the protection of mice from intestinal inflammation,
presumably via induction of alternatively activated macrophages
(AAMs) (7–9). As a major source of IL-4 in helminth
infections, including schistosomiasis, basophils have been
identified (10–12).
Schistosome eggs have been shown to secrete proteins with
putative immunomodulatory functions (13). The major secreted
product is the glycoprotein IPSE/alpha-1, representing 80% of
the egg secretions (14). Previously, we found that IPSE/alpha-1
triggers the release of IL-4 and IL-13 from human and murine
basophils (15, 16), suggesting that this molecule is involved
in inflammation control in schistosomiasis. IPSE/alpha-1 is a
general immunoglobulin-binding factor that binds with highest
affinity to the IgE isotype (17). Upon interaction with IgE bound
to the FcεRI receptor on the surface of basophils, IPSE/alpha-
1 activates basophils to release IL-4 and IL-13. Removal of
IgE from the receptor (IgE stripping) abrogates the activation,
while resensitization with IgE restores the cytokine releasing
activity of IPSE/alpha-1 on basophils (16, 18). Noteworthy
binding of IPSE/alpha-1 to IgE is independent of the IgE
specificity (17). Structure analysis revealed that IPSE/alpha-1
belongs to the beta-gamma crystallin family (17). Moreover,
IPSE/alpha-1 has a C-terminal functional nuclear localization
sequence (NLS) for translocation into the nucleus (19). Natural
IPSE/alpha-1 is N-glycosylated and contains Lewis X-motifs
(20). Glycosylation is essential for binding to and uptake
from monocyte-derived dendritic cells, presumably via lectin
receptors (19). However, induction of IL-4 and IL-13 from
basophils does not require uptake of IPSE/alpha-1 into the
basophils and is independent of NLS and glycosylation (16,
19).
Recently, further immunomodulatory functions of
IPSE/alpha-1 have been described: IPSE/alpha-1 was shown
to be able to induce development of regulatory B cells (21). A
mutant of IPSE/alpha-1, called SmCKBP (S. mansoni chemokine
binding protein) was found to bind to chemokines (IL-8), thus
neutralizing pro-inflammatory cytokines (22). Noteworthy,
SmCKBP is not able to activate basophils. This is due to one
of two amino acid exchanges (T92Y and R127L). T92 was
mapped by NMR titrations in the putative IgE binding site of
IPSE/alpha-1, which is important for interaction and subsequent
activation of basophils (17).
Finally, an IPSE/alpha-1 homolog (named H-IPSE) was
identified in S. haematobium (23). Also H-IPSE is able to
translocate into the nucleus of cells via a functional nuclear
localization sequence and to induce IL-4 release from murine
basophils (24).
Given the importance of IL-4 and IL-4 signaling for host
protection, and knowing that basophils are a source of IL-4, we
asked in this study whether IPSE/alpha-1, as a potent inducer
of basophil IL-4/IL-13, might be involved in the control of
inflammation in schistosomiasis.
MATERIALS AND METHODS
Recombinant IPSE/alpha-1
IPSE/alpha-1 was expressed in E. coli and refolded as described
in detail by Schramm et al. (16) The LPS content of the
recombinant E. coli-expressed IPSE/alpha-1 preparation was
98 ng/mg protein as determined by Limulus amebocyte lysate
(LAL) assay (Haemochrom). E. coli-expressed IPSE/alpha-
1 is not glycosylated in contrast to the natural protein.
However, the glycosylation is not involved in the basophil IL-4-
inducing function. Natural and E. coli-expressed unglycosylated
IPSE/alpha-1 induced comparable amounts of cytokines from
human basophils (16).
Isolation of Human Peripheral Blood Cells
Co-cultures were performed with monocytes and basophils
obtained from the same donor (autologous system). Monocytes
and basophils were isolated from 250ml of peripheral blood from
healthy donors. Ethylene diamine tetra-acetic acid (EDTA) blood
was divided into two parts and separated via density gradient
centrifugation, one half for isolation of monocytes via Ficoll
(density 1.077 g/l), and the other half for isolation of basophils
via Ficoll / Percoll (100/6, density 1.080 g/l). At a density of 1.080
g/l the interphase contains bothmononuclear cells and basophilic
granulocytes. The respective cell populations were then enriched
via counter flow elutriation. Basophils were further purified by
magnetic cell sorting (MACS) using the basophil isolation kit
II for negative selection of basophils (Miltenyi-Biotech). The
whole three-step protocol for basophil isolation was described
by Haisch et al. (21). Across the samples, ≥98% purity was
achieved. Purity was determined by microscopic assessment of
May-Gruenwald-stained cytospins.
Ethics Statement
Peripheral blood was taken from adult healthy donors. All
donors provided written informed consent (Ethics approval by
the Ethics Committee of the University of Luebeck; AZ-12-
202A). Experiments that used mice for obtaining mouse tissue
for immunofluorescence stainings were approved by the Ethical
Review Committee of the University of Nottingham in which
these materials were produced and the work was carried out in
strict accordance with UK government regulations for animal
welfare and amelioration of suffering in force at the time. The
work was licensed under legislation specified by the UK Animals
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(Scientific Procedures) Act 1986, (project license numbers PPL
40/3024 and 40/3595). Animals were killed by administration of
a lethal dose of pentobarbitone anesthetic.
Experiments that used mice for obtaining mouse tissue
for immunohistochemical stainings were performed according
to the Danish Act on Animal Experimentation (LBK no.
474 of 15/05/2014). The study was approved by the Animal
Experimentation Inspectorate, Ministry of Environment and
Food, Denmark (license no. 2015-15-0201-00694).
Cell Culture and Stimulation
Cell culture was performed in Iscove’s Modified Dulbecco’s
Media (IMDM; PAA) containing 2mM glutamine (PAA),
5µg/ml insulin (Gibco), 50µg/ml apo-transferrin (Sigma-
Aldrich), 100µg/ml Pen/Strep (PAA), 10% heat-inactivated
Fetal Calf Serum (FCS-Gold; PAA) and 2.5 ng/ml IL-3 (kind
gift of Kirin Brewery, Japan). IL-3 was added to all cultures
containing basophils as a survival factor for basophils (25). For
co-culture, autologous monocytes and basophils were incubated
in a 1:1 ratio, i.e., 250,000 monocytes and 250,000 basophils
in 1ml culture medium per well in 24-well flat-bottom culture
plates. Following purification, basophils were pre-incubated for
regeneration for 30min at 37◦C, 6% CO2 before they were added
to the monocytes. Stimuli were added to a final concentration
as follows: 10 ng/ml LPS (Salmonella friedenau, kind gift of
Prof. H. Brade, RCB), 120 pg/ml recombinant human IL-4
(rhIL-4) (Immunotools), 100 ng/ml recombinant IPSE/alpha-
1. Cells were co-cultured for 24 h, unless specified otherwise,
and were harvested and analyzed at the flow cytometer LSR
II (BD Biosciences). Stimulation of basophils was additionally
performed with 50 ng/ml goat anti-human IgE (Dianova) as
positive control for IgE receptor-mediated stimulation, and with
2µM ionomycin for induction of maximal cytokine release.
All stimulations of basophils, except with ionomycin, were
performed in the presence of IL-3 at a concentration of 2.5 ng/ml
for induction of IL-4 release and at a concentration of 0.1 ng/ml
for induction of IL-13 release, since higher concentrations of
IL-3 per se induce IL-13 release from basophils. Supernatants
were kept at −80◦C until analyzed for cytokine production by
the respective cytokine-specific ELISAs: IL-1β and IL-6 from
monocytes (BD Biosciences); IL-4 and IL-13 from basophils
(Diaclone). Measurement was performed using the ELISA-
Reader SunRise (Tecan).
Analysis of Expression of Surface Markers
on Monocytes and TLR on Basophils by
Flow Cytometry (LSRII)
Expression of the surface markers CD206 and CD209 on
monocytes and TLR1, 2, 4, and 6 on basophils was analyzed
by flow cytometry following staining with specific fluorescent-
labeled antibodies. Monocytes were stained with FITC-anti-
human CD206 and PE-anti-human CD209, obtained from
BD Biosciences. Basophils were stained with biotin-labeled-
anti-TLR1 followed by PerCP-streptavidin, AF647-labeled anti-
TLR2, BV421-labeled anti-TLR4, and PE-labeled-anti-TLR6,
respectively, obtained from Biolegend. Staining was performed
in 96-well V-bottom plates with 50,000 monocytes or 125,000
basophils per well in 20 µl of the respective antibodies diluted
1:20 in FACS staining buffer (10% FCS, 1%HS, 0.5% BSA in PBS).
For control, cells were left unstained, and single stained (CD206,
CD209). For compensation controls, we used compensation
beads (BD CompBead Plus, BD Biosciences). Measurement was
performed on the BD LSRII cytometer and data were analyzed
with DIVA 8.0 software (BD Biosciences).
Immunohistology
Sections of S. mansoni-infected or uninfected paraffin-
embedded mouse tissues [liver and intestine/ileum from
random-bred CD1 mice (Charles River, UK)] were stained for
basophils with the basophil-specific rat anti-mMCP-8 antibody
(clone TUG8, Biolegend), either by immunofluorescence or
immunohistochemically. For immunofluorescence, anti-mMCP-
8 was diluted 1:500. Binding was detected by AF-633-labeled
secondary rabbit anti-rat IgG (Invitrogen), dilution 1:1000.
Nuclei were counterstained by DAPI (Invitrogen; dilution
1:1,000), and pictures were taken with an Olympus IX-81
inverse fluorescence microscope (Olympus). Sections of
S. mansoni-infected paraffin-embedded mouse liver tissue
from female C57BL/6-NTAC mice (Taconic, Denmark) were
immunohistochemically stained the anti-mMCP-8 and the
secondary biotinylated rabbit anti-rat antibody were diluted
1:100, and detection was performed using the Vectastain
Kit (Vector Laboratories). For detection of IPSE/alpha-1 the
monoclonal antibody anti-IPSE/alpha-1 (clone 74 1G2) (16),
was biotinylated according to standard protocols and diluted
1:100. To prevent non-specific binding to the mouse tissue,
the M.O.M. Peroxidase kit (Vector laboratories) was applied.
Mayer‘s hematoxylin (Merck) was used for counter staining.
Pictures were taken at the Olympus BX51 microscope.
Isolation of RNA From Basophils and
Analysis of TLR Expression by RT-PCR
With TLR-Specific Primers
RNA was isolated from basophils with a purity ≥99% using
the “Direct-zol RNA MiniPrep Kit” from Zymo Research
and reversely transcribed into cDNA using the “RevertAid H
Minus First Strand cDNA synthesis Kit” (Thermo Scientific). A
minimum of 5 × 106 basophils was required to obtain sufficient
amount of RNA. The RNA was either stored at −80◦C or
subjected immediately to the reverse transcription reaction. DNA
concentration and quality was controlled with the Nanodrop
photometer (Peqlab). Specific TLR cDNA was amplified by the
following PCR protocol: pre-denaturation step at 95◦C for 15min
followed by 40 cycles of denaturation at 94◦C for 30 s, annealing
at 55◦C for 30 s, extension at 72◦C for 60 s, followed by a
final extension step at 72◦C for 10min before cooling to 4◦C.
Amplification was performed using the Maxima Hot Start DNA
Polymerase (Thermo Scientific). Table 1 shows the sequences of
the applied TLR-specific primers. A negative control reaction
was performed without cDNA template and a positive control
using specific primers for the housekeeping gene GAPDH. PCR
products were analyzed on 1% agarose gels together with the
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TABLE 1 | GAPDH and TLR-specific primer sequences.
Sequence forward Sequence reverse bp
GAPD 5′-TGATGACATCAAGGTGGTGAAG-3′ 5′-TCCTTGGAGGCCATGTGGGCCAT-3′ 240
TLR1 5′-TATTGGGCACCCCTACAAAA-3′ 5′-CCAATTCCTGGTTGAATTTGA-3′ 375
TLR2 5′-GGGTCTTGGGGGTCATCATCA-3′ 5′-CAAGACTGCCCAGGGAACAAAAAC-3′ 282
TLR3 5′-AGGATTGGGTCTGGGAACAT-3′ 5′-GCCAGTTCAAGATGCAGTGA-3′ 339
TLR4 5′-AGAACTGCAGGTGCTGGATT-3′ 5′-TCATAGGGTTCAGGGACAGG-3′ 413
TLR5 5′-TTAAACAACCAGGGACCCTCT-3′ 5′-TAAGGTTGGGCAGGTTTCTG-3′ 517
TLR6 5′-TCACAATTCAGTTTCCACC-3′ 5′-CACAGTCACAGCCAACACC-3′ 296
TLR7 5′-TGCTCTGCTCTCTTCAACCA-3′ 5′-TTTGACCCCAGTGGAATAGG-3′ 377
TLR8 5′-TGCTGCAAGTTACGGAATGA-3′ 5′-ATTTTGCAGCCCTTGAAATG-3′ 371
TLR9 5′-GAAGGGACCTCGAGTGTGAA-3′ 5′-AAGTGGGGCACAGACTTCAG-3′ 255
TLR10 5′-GAGAAGCTGGCAACATGTCA-3′ 5′-CTTTCTTCTGGCAGCTCTGG-3′ 495
“MassRuler DNA Ladder Mix” from Thermo Scientific (marker
1) and the “100 bp ladder” from Promega (marker 2).
Statistical Analysis
Statistical analysis was performed using the Graph Pad Prism6
software (GraphPad Software, San Diego, CA). Since human
primary immune cells have a highly variable individual reactivity,
the co-culture data were normalized and analyzed using
Wilcoxon matched-pairs signed rank test or paired t-test. To
determine significance between three or more data sets, the
two way ANOVA multiple comparison test was performed as
indicated in the figure legends. A p-value smaller than 0.05 was
considered statistically significant. Data are presented as ±SEM
and sample sizes are given in the figure legends.
RESULTS
IPSE/alpha-1-Induced Basophil IL-4 and
IL-13 Inhibited Pro-inflammatory Cytokine
Release From LPS-Activated Monocytes
in vitro
Human monocytes were isolated from peripheral blood of
healthy donors, and were co-cultured with autologous basophils
in a ratio of 1:1 in the presence of LPS, with or without
IPSE/alpha-1. As control, monocytes were cultured without
basophils in medium alone, and stimulated with LPS ±
recombinant human IL-4 (rhIL-4). Figure 1 shows the results of
14 individual experiments. Monocytes released large amounts of
the pro-inflammatory cytokines IL-1β and IL-6 upon activation
with LPS. Since monocytes from individual human blood
donors exhibited high variability in cytokine release, values
were normalized by defining maximum LPS-induced cytokine
release as 100%. The pro-inflammatory cytokine production
of monocytes was significantly inhibited when exogenous
recombinant human IL-4 was added. Co-culture with basophils
alone without additional stimuli led to an inhibition in the
production of IL-1β and IL-6. This inhibition was significantly
enhanced when IPSE/alpha-1 was added to the co-culture
(Figures 1A,B). Notably, the inhibitory effect significantly
correlated with the amount of IL-4 and IL-13 released from the
basophils (Wilcoxon matched-pairs signed rank test p < 0.001;
Figures 1C,D). Since IPSE/alpha-1 is a general immunoglobulin-
binding factor (17), with the potential to bind to receptors with
immunoglobulin-like domains on the surface of cells and thus,
could activate or inhibit their functions, we investigated the effect
of IPSE/alpha-1 by itself (i.e., in the absence of basophils) on
monocytes. We found that IPSE/alpha-1 did not inhibit, but—
on the contrary—slightly induce pro-inflammatory cytokine
release. This may be due to small amounts of contaminating LPS
impurities in the recombinant IPSE/alpha-1 preparations from
E. coli (Figure 2).
Inhibition of Pro-inflammatory Cytokine
Release From LPS-Activated Monocytes
by IPSE/alpha-1-Stimulated Basophils
Depended on Soluble IL-4 and Led to an
“Alternatively Activated” Phenotype of the
Monocytes
To demonstrate that basophil-derived IL-4 was responsible for
the inhibition of pro-inflammatory cytokine release from LPS-
activated monocytes, the co-culture described in the previous
section was repeated in the presence of anti-IL-4 antibody
and, as a negative control, an anti-IgG/M antibody with
irrelevant specificity. Inhibition was completely abrogated in
the presence of anti-IL-4, whereas addition of anti-IgG/M
had no effect (Figure 3). Moreover, pro-inflammatory cytokine
release was inhibited by culturing LPS-activated monocytes in
basophil supernatant (BaSN), with the basophils stimulated
before with IPSE/alpha-1 or anti-IgE (Figures 4A,B). Likewise,
addition of anti-IL-4 antibodies abrogated also the inhibitory
effect of supernatant of IPSE/alpha-1-stimulated basophils (data
not shown). Taken together, these experiments confirm that
inhibition of pro-inflammatory cytokine release from LPS-
activated monocytes was IL-4-dependent, but cell/cell contact-
independent.
Since IL-4 and IL-13 induce AAMs, we investigated the
monocytes cultured in basophil-conditioned medium for the
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FIGURE 1 | IPSE/alpha-1-triggered basophil IL-4 inhibited the release of IL-1β and IL-6 from human LPS-activated monocytes. Release of IL-1β (A) and IL-6 (B) from
monocytes, and IL-4 (C) and IL-13 (D) from basophils. Monocyte-derived cytokine release (A,B) was normalized to the maximum release following LPS activation
(100%). Note, rhIL-4 was only very poorly detected by the IL-4 ELISA (Diaclone), because the monoclonal antibodies in this ELISA are directed against natural IL-4
and do not bind properly to the recombinant IL-4. Data are presented as mean ± SEM, IL-1β and IL-6: n = 14; IL-4: n = 13; IL-13: n = 11. Statistics were performed
with the Wilcoxon matched-pairs signed rank test (A,B) or paired t-test (C,D); * = significance “LPS + additions (IL-4, basophils, basophils + IPSE)” vs. “LPS without
additions”; **p < 0.01, ***p < 0.001, ****p < 0.0001; # = significance “basophils with IPSE/alpha-1” vs. “without IPSE/alpha-1”; ##p < 0.01, ###p < 0.001,
####p < 0.0001.
FIGURE 2 | IPSE/alpha-1 had limited direct effect on the pro-inflammatory cytokine release of monocytes. IL-1β (A) and IL-6 (B) released from human monocytes
stimulated with LPS, rhIL-4, IPSE/alpha-1 or combinations thereof. While rhuIL-4 had a significant inhibitory effect on the LPS-induced IL-1-β and IL-6 release from
monocytes, IPSE/alpha-1 alone had only very little (IL-1β) or virtually no (IL-6) direct effect on LPS-activated monocytes with respect to inhibition of cytokine release.
Pro-inflammatory cytokine release directly induced by IPSE/alpha-1 is the result of small amounts of LPS in E. coli-expressed IPSE/alpha-1. Data are presented as
mean ± SEM, n = 7. Statistics were performed with the paired t-test; ns, not significant, *p < 0.05, ***p < 0.001, ****p < 0.0001.
expression of CD206 (mannose receptor) and CD209 (DC-
SIGN). Humanmonocytes freshly isolated from peripheral blood
did not express CD206 or CD209 (not shown). Figures 4C,D
show, that following culture in medium for 24 h, the percentage
of CD206- and CD209-expressing monocytes increased to 22
and 12%, respectively. In the presence of LPS, only slight
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FIGURE 3 | Anti-IL-4 abrogated the inhibitory effect of IPSE/alpha-1-triggered
basophil-derived IL-4. Release of IL-1β (A) and IL-6 (B) from monocytes
co-cultured with autologous basophils without (black bars) or with anti-IL-4
antibodies (gray bars) or with anti-IgG/M (bars with pattern) as control
antibody. Inhibition of both IL-1β and IL-6 from LPS-activated monocytes was
abrogated by anti-IL-4, while anti-IgG/M had no effect on the inhibition. Data
were normalized to the maximum release following LPS activation (100%).
Data are presented as mean ± SEM, n = 4 for anti-IL-4 and n = 2 for
anti-IgG/M. Statistics were performed by two way ANOVA multiple
comparison test; * = significance “LPS + additions (IL-4, basophils, basophils
+ IPSE)” vs. “LPS alone”; *p < 0.05, **p < 0.01, ****p < 0.0001.
increase in CD206 or CD209 expression was observed (up to
1.9 and 0.8%, respectively). However, culturing LPS-activated
monocytes in the supernatant of IPSE/alpha-1- or anti-IgE-
stimulated basophils, elevated the expression of CD206 and
CD209 up to 5 and 11%, respectively (Figures 4C,D). These
results indicate that IPSE/alpha-1-induced IL-4 from basophils
induced an alternatively activated-like phenotype in human
monocytes.
Basophils and IPSE/alpha-1 Were Detected
in S. Mansoni Egg Granulomas
Schistosome eggs deposited in host tissue attract a variety
of immune cells, resulting in the formation of a granuloma
around the eggs (4). The granuloma provides a defined area
for close contact and interaction between egg-secreted products
and host immune cells. Typically, schistosome eggs induce a
Th2-granuloma, containing Th2 cells, B cells, eosinophils and
AAMs (4). The amounts of IL-4 needed to create such a Th2-
polarized immune response and induce AAMsmight be provided
by stimulation of basophils by egg-secreted IPSE/alpha-1. Thus,
we investigated whether basophils are present in the granuloma,
and whether they are in close contact with IPSE/alpha-1.
Sections of S. mansoni-infected mouse liver and gut (ileum)
were stained with the basophil-specific antibody rat anti-mouse
mast cell protease (mMCP)-8 and detected by fluorescence
microscopy following incubation with the detection antibody
AF633-labeled rabbit anti-rat IgG (Figure 5). Basophils (stained
in magenta) could be clearly detected in the granulomas around
the eggs, but not in the other areas of the infected tissues or in
tissue of uninfected mice.
IPSE-alpha-1 is the major excretory/secretory product
from mature eggs of S. mansoni (14). Thus, it would be
expected to come into close contact with immune cells,
i.e., with basophils in the granuloma surrounding the
egg during its migration through the tissue. We stained
sections of liver from S. mansoni-infected mice with the
biotinylated anti-IPSE/alpha-1 monoclonal antibody 74-1G2
for IPSE/alpha-1 (Figure 6A) or with the anti-mMCP-8
antibody and a biotinylated rabbit anti-rat IgG for basophils
(Figure 6B). Detection was performed immunohistochemically
by streptavidin-labeled peroxidase. Both, IPSE/alpha-1 and
basophils were detected in the granulomas. Eggs differed in
their expression of IPSE/alpha-1, presumably representing
different maturation stages (i.e., times after egg deposition).
Figures 6Aa, left box and Ab show eggs, which do not express
IPSE/alpha-1, presumably freshly deposited eggs in early
granulomas, while Figures 6Ac, right box and Ad show
advanced granulomas with pronounced IPSE/alpha-1 staining in
the subshell area and outside the eggs.
Basophils were detected in small granulomas close to the eggs
(Figures 6Ba,Bb), but in large granulomas mainly in the outer
rim (Figures 6Bc,Bd).
IgE-Dependent Cytokine Release From
Basophils Was Boosted by Simultaneous
TLR Ligation
Upon release of schistosome eggs into the gut lumen,
granuloma cells come into contact with bacteria and
bacterial products, and thus ligands for Toll-like receptors
(TLRs). To assess the effect of LPS on basophils present
in the granuloma, we investigated the expression of TLRs
on basophils, and the release of IL-4 and IL-13 following
simultaneous activation of basophils via the TLR and Fcε
receptor (FcεRI).
To analyze the expression of TLR by basophils, we isolated
mRNA from human basophils purified from peripheral blood
of 12 individual healthy donors, and performed reverse
transcription-polymerase chain reaction (RT-PCR) with TLR-
specific primers.
TLR expression differed in individual donors (see Figure 7A
for expression of TLR1 to TLR10 mRNA in basophils of four
out of 12 investigated donors as examples of distinct TLR
expression patterns, and Table 2 for TLR expression of all
investigated donors). We did not observe differences between
allergic and non-allergic individuals or so-called “releasers” and
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FIGURE 4 | Culture of LPS-activated monocytes in supernatant from IPSE/alpha-1-stimulated basophils resulted in inhibition of pro-inflammatory cytokine release and
increased numbers of CD206- and CD209-positive monocytes. IL-1β (A) and IL-6 (B) release from monocytes, and CD206 (C) and CD209 (D) expression on
monocytes cultured with supernatant from basophils (BaSN). Monocyte-derived cytokine release was normalized to the maximum release following LPS activation
(100%). Data are presented as mean ± SEM, n = 9 (anti-IgE: n = 5). Statistics were performed by paired t-test; significance was shown for “LPS with BaSN” vs. “LPS
without BaSN” (black bar); *p < 0.05, ***p < 0.001, ****p < 0.0001.
“non-releasers” (donors whose basophils release or do not release
histamine upon stimulation with anti-IgE).
To verify these results in terms of the effect on protein levels,
we stained basophils of one example donor 29 with fluorescence-
labeled antibodies against the surface-expressed TLR1, 2, 4,
and 6, with analysis performed by flow cytometry (Figure 7B).
Consistent with the RT-PCR results, basophils of this donor
expressed TLR2 and TLR6 but only little TLR1 and TLR4.
To investigate the influence of LPS on IgE-receptor-
mediated cytokine release from basophils, purified basophils
were stimulated with LPS, anti-IgE or IPSE/alpha-1 alone, or
anti-IgE or IPSE/alpha-1 in the presence of LPS. Basophils
were cultured in the presence of IL-3, a survival factor for
these cells. Intact functionality of the basophils was controlled
by stimulation with ionomycin that induces maximal cytokine
release. LPS differentially affected basophil IL-4 and IL-13 release:
The IL-4 release induced by LPS was low compared to that
induced by anti-IgE, while the IL-13 release induced by LPS
was comparable to that induced by anti-IgE (Figures 8A,B).
Simultaneous stimulation of basophils with LPS (via TLR4) and
anti-IgE or IPSE/alpha-1 (via FcεRI-bound IgE) enhanced both
the IL-4 and IL-13 release induced by anti-IgE or IPSE/alpha-
1 alone (Figures 9A–D). Boosted IL-4 and IL-13 release from
anti-IgE-stimulated basophils—although to a lesser extent—
was also observed when basophils were co-stimulated with the
TLR2/6 agonist di-acyl lipopeptide FSL-1 (Pam2CGDPKHPKSF)
(data not shown). This suggests that basophils stimulated
simultaneously by both, FcεRI and TLR, can provide very high
local IL-4 and IL-13 concentrations.
IPSE/alpha-1-Induced Basophil IL-4 and
IL-13 Inhibited Pro-inflammatory Cytokine
Release From LPS-Activated Monocytes in
the Context of Whole PBMC
In vivo schistosome egg granulomas consist of a variety of
immune cells that are also found in whole peripheral blood
mononuclear cells (PBMC), specifically B cells, T cells, and
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FIGURE 5 | Basophils were detected in the egg granulomas in tissue of S. mansoni-infected mice. Liver (A,C,E) and gut (ileum) (B,D,F) of S. mansoni-infected mice
(A,B,E,F) and uninfected control mice (C,D); Nuclei are shown stained in blue; basophils (stained in magenta) were detected exclusively in S. mansoni-infected mouse
tissue, i.e., in the granulomas. Note the autofluorescence of the schistosome egg shell (green). (E,F) are negative controls without the primary antibody anti-mMCP-8.
Scale bars are 200µm.
eosinophils (4).We therefore investigated whether IPSE/alpha-1-
triggered basophil IL-4/IL-13 inhibits pro-inflammatory cytokine
release (IL-1β, IL-6 and TNF-α) from monocytes in the context
of PBMC. We found that, similar to the monocyte-basophil co-
culture, pro-inflammatory cytokine production was significantly
inhibited in the presence of IPSE/alpha-1 and basophils. The
inhibitory capacity correlated with IL-4/IL-13 release from
IPSE/alpha-1-triggered basophils (Figure 10). Thus, IPSE/alpha-
1 has the potential to control inflammation during S. mansoni
infection via basophil-IL-4 both in the context of isolated
monocytes and whole human PBMC.
DISCUSSION
Here, we demonstrated that IL-4/IL-13 produced by IPSE/alpha-
1-stimulated basophils inhibited the release of the pro-
inflammatory cytokines IL-1β, IL-6 and TNF-α from LPS-
activated monocytes. LPS-activated monocytes cultured in
the presence of IPSE/alpha-1-stimulated basophils or their
supernatants developed a phenotype similar to AAMs, with
elevated expression of CD206 (mannose receptor) and CD209
(DC-SIGN). Using specific antibodies, both IPSE/alpha-1 and
basophils were detected in the granuloma around schistosome
eggs in sections of liver and gut of infected mice, indicating
that basophils come into close contact with IPSE/alpha-
1. Importantly, TLR ligation (which occurs when bacterial
products enter the host via egg-induced gut lesions) boosted
the IPSE/alpha-1-induced IL-4/IL-13 release from basophils,
thus providing high local IL-4/IL-13 concentrations. Finally,
IPSE/alpha-1 also had an anti-inflammatory effect when
basophils were co-cultured with whole PBMC instead of purified
monocytes.
The eggs of S. mansoni are responsible for the clinical impact
of schistosomiasis by inducing granulomatous inflammation
in liver and intestinal tissues (3). While migrating through
the tissue to reach the gut lumen, the eggs exert both pro-
and anti-inflammatory effects. Inflammation is necessary to get
the eggs out of the host to complete the life cycle of this
parasite (5, 26). However, open migration channels left by
eggs that penetrate the gut wall are invaded by gut microbiota
(and their products), resulting in excessive inflammation if not
strictly controlled. The hallmark of the immune response toward
schistosomes is the induction of a Th2 response during acute
schistosomiasis, which shifts during the chronic infection phase
toward a modified or regulated Th2 response characterized
by regulatory T and B cells and AAMs (27). Responsible
for Th2 induction as well as subsequent immunosuppression
are the schistosome eggs, which secrete immunomodulatory
factors (4). There are varying informations on the number
of excretory/secretory products of schistosome eggs in the
literature ranging from 188 to five (28). According to Mathieson
et al. (14) and our own unpublished findings, schistosome
eggs release only few excretory/secretory proteins with different
isoforms at notable amounts—these include the glycoproteins
IPSE/alpha-1 and omega-1. IPSE/alpha-1 had been shown to
induce IL-4 and IL-13 release from basophils (16), while omega-
1 conditions dendritic cells to polarize naïve T helper cells
toward Th2 (22). Notably, IPSE/alpha-1 represents more than
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FIGURE 6 | Detection of IPSE/alpha-1 and basophils in schistosome egg granulomas. Sections of S. mansoni-infected murine liver were stained for IPSE/alpha-1
(anti-IPSE/alpha-1; A) and basophils (anti-mMCP-8; B). Depicted are two magnification, each. Scale bars are 200µm for 100x magnification and 50µm for 400x
magnification. (a,b) Show small granulomas with presumably immature eggs without IPSE/alpha-1 production (Aa, left box, Ab) and with basophils detected near the
egg (Ba,Bb). (c,d) Show advanced granulomas with strong IPSE/alpha-1 staining in the subshell area and outside the eggs (Ac right box, Ad) and with basophils
detected mainly in the outer rim of the granuloma (Bc,d). (e,f) Show negative controls without the respective primary antibodies.
FIGURE 7 | Individual TLR expression on human basophils as assessed by RT-PCR and surface staining followed by flow cytometry. (A) Expression of TLR1−10
cDNA as assessed by RT-PCR of four individual donors shown as an example for distinct expression patterns. The full set of donors are listed in Table 2. (B)
Expression of the surface-exposed TLR1, 2, 4, and 6 on basophils of donor 29 measured by flow cytometry. Depicted are the histogram overlays of unstained (light
gray) and with the respective fluorescently-labeled antibody stained (dark gray) basophils.
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TABLE 2 | Individual TLR expression on human basophils as assessed by
RT-PCR with TLR-specific primers.
Donor TLR1 TLR2 TLR3 TLR4 TLR5 TLR6 TLR7 TLR8 TLR9 TLR10
2 + + + + + +
3 + + + + + + + + + +
4 + + + + + + + +
8 + + + + + +
13 + + + + + + +
26 + + + + +
29 + + + +
36 + + + +
184 + + + + + + + +
200 + + + + +
203 + + + + + + + +
224 + + + + +
TLR 2 and TLR 6 were detected on all investigated donors (dark gray shaded). Light
gray-labeled donors are shown as examples of distinct TLR expression patterns in
Figure 7A.
80% of the egg secretions (14) underlining its importance for
host parasite interaction. Depletion experiments with antibodies
to IPSE/alpha-1 have shown, that IPSE/alpha-1 is the only
compound in egg secretions and even in whole extract of
schistosome eggs (SmEA) able to trigger basophils for IL-4 and
IL-13 release (16, 17).
IL-4 and IL-13 are well known as Th2 key cytokines, and
naïve T helper cells develop in the presence of IL-4 into Th2 cells
(29, 30). Thus, the basophil IL-4-inducing activity of IPSE/alpha-
1 makes this molecule a very likely candidate for Th2 induction
in schistosome infection (31). Indeed, recently, a number of
studies have demonstrated that basophils are able to induce
Th2 responses (32–34). However, the Th2-inducing ability of
basophils could not be confirmed by others (35), and also
the basophil IL-4/IL-13 production triggered by IPSE/alpha-1
failed to induce a Th2 response in vitro or in vivo (15, 36). In
contrast, omega-1, the second well characterized egg-secreted
glycoprotein, has been shown to initiate an IL-4-independent
Th2 response via conditioning of dendritic cells in vitro and
in vivo, while IPSE/alpha-1 did not (36, 37). These data suggest
that IPSE/alpha-1-triggered basophil IL-4 production is not
involved in Th2 induction.
Thus, we asked, what could be the function of IPSE/alpha-1-
induced basophil-derived IL-4 and IL-13? Several studies have
demonstrated the protective role of AAMs in schistosomiasis
(38, 39), and that they are induced by IL-4 and IL-13 (40).
However, the source of these two cytokines is still a matter of
debate. A recent study reported that Th2 cells are sufficient, and
that basophils are not needed for protection during schistosome
infection (41). However, other studies have shown that IL-4 from
FcεRI+, non-B, non-T cells are responsible for protection (42)
and that basophils are the major source for IL-4 (11, 12). These
contradictory outcomes might result from different knock-out
mouse models in combination with different parasite infection
models (intestinal vs. tissue-dwelling parasites).
The relevance of basophil-derived IL-4 in inflammation
control got further support by a recent in vitro study showing
that basophil IL-4 and IL-13 promote alternative activation
of human monocytes (43). Moreover, in a mouse model
of chronic IgE-mediated skin allergy, IL-4 from basophils
recruited to inflamed skin converted inflammatory into anti-
inflammatory M2-macrophages (44, 45), while depletion of
basophils exaggerated disease in mouse models for autoimmune
colitis (46) as well as for multiple sclerosis [experimental
autoimmune encephalomyelitis (EAE)] (47).
The traditional view of basophils as pro-inflammatory effector
cells providing mediators (histamine) and cytokines (IL-4/IL-13)
to induce and/or amplify a Th2 response in parasite infection and
allergy has been further questioned recently by studies showing
that after binding to the H2 receptor, histamine enhanced
anti-inflammatory IL-10 production by dendritic cells (48).
Moreover, depending on the cytokine environment (IL-3 vs.
TSLP), basophils have been shown to preferentially release either
histamine or IL-4 (49), and that TLR-activated basophils release
Th2 cytokines but do not degranulate (50). Together, the data
imply a new role for basophils as potential source of IL-4/IL-
13 for induction of an anti-inflammatory immune response and,
thus, a paradigm shift from basophils as purely inflammatory
effector cells to anti-inflammatory, wound-healing, resolution
phase cells.
The glycoprotein IPSE/alpha-1, secreted from live
schistosome eggs, triggers the release of IL-4/IL-13 from
basophils, suggesting that this molecule is the link between
schistosome eggs and basophil-released IL-4/IL-13 for
the induction of AAMs and inflammation control in
schistosome infection. A recent study supported a potential
anti-inflammatory role of IPSE/alpha-1. H-IPSE, a homologous
molecule in S. haematobium (23), was used for treatment of
ifosfamide-induced hemorrhagic cystitis (IHC) in mice (24).
Administration of H-IPSE reduced IHC-induced bladder
hemorrhage in an IL-4-dependent manner. Thus, the basophil
IL-4-inducing activity of IPSE/alpha-1 and homologs in other
schistosome species might open up new directions for therapy of
inflammatory diseases.
The capacity of IL-4 to activate anti-inflammatory
macrophages (that possess wound-healing and resolution
phase properties) has been used to enhance repair and functional
recovery after spinal cord injury by a single intraspinal injection
of IL-4 (51, 52) and to improve integration of implants coated
with an IL-4-eluting matrix (52). Noteworthy, IL-4 and IL-13
exert a number of anti-inflammatory functions, in addition
to alternative activation of macrophages (53, 54), including
inhibition of pro-inflammatory cytokine release from LPS-
activated monocytes, such as IL-1β, IL-6 and TNF-α (55) and
inhibition of Th17 responses (55–57).
In the present study we showed that IPSE/alpha-1-induced
basophil IL-4 inhibited pro-inflammatory cytokine release from
LPS-activated monocytes, and moreover, that monocytes co-
cultured with IPSE/alpha-stimulated basophils developed
an AAM-like phenotype. For human AAMs, especially
in the context of schistosome granulomas, the mannose
receptor CD206 has been proposed as a characteristic
marker (58, 59). This was supported by our data: culturing
human LPS-activated monocytes in the presence of IL-4-
containing basophil supernatant increased the expression
of CD206-positive monocytes from two to 11%. Similarly,
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FIGURE 8 | IL-4 and IL-13 release from basophils following stimulation with LPS. IL-4 (A) and IL-13 (B) release from basophils stimulated with different concentrations
of LPS in comparison to anti-IgE. All stimulations were performed in the presence of IL-3. Data are presented as mean ± SEM; (A) n = 7, (B) n = 5.
FIGURE 9 | Enhanced FcεRI-dependent IL-4 and IL-13 release from basophils by simultaneous stimulation with LPS (via TLR4). IL-4 (A,C) and IL-13 (B,D) release
from basophils stimulated anti-IgE ± LPS (A,B), or IPSE/alpha-1 ± LPS (C,D). Data are presented as mean ± SEM; (A) n = 7; (B) n = 5; (C) n = 9; (D) n = 4.
Statistics data were performed by ratio paired t-test; significance is shown as with vs. without LPS; ***p < 0.001, ****p < 0.0001.
the percentage of CD209 (DC-SIGN)-positive monocytes
increased from 0.8 up to 22%, suggesting CD209 is also a
suitable marker for human AAMs. We did not detect other
proposed surface markers for human AAMs on in vitro-
generated human AAMs, such as CD163 and CD200R (although
CD200R was clearly detectable on the surface of basophils)
(60–62).
Immunohistology was performed on schistosome-infected
tissue to address the question whether IPSE/alpha-1 meets
basophils in vivo, i.e., in the granuloma. Since samples from
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FIGURE 10 | IPSE/alpha-1-triggered basophil IL-4 inhibited the release of IL-1β (A), IL-6 (B), and TNF-α (C) from LPS-activated monocytes in the context of whole
PBMC. Inhibition correlated with IL-4 (D) and IL-13 (E) release from basophils. The experiment shown in Figure 1 was repeated with PBMC instead of purified
monocytes. Data for PBMC are presented as mean ± SEM, n = 4; (TNF-α: n = 3). Statistics were performed with the paired t-test; significance was shown vs. LPS
without additions; ns, not significant, *p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001.
infected humans were not available, immunohistology with
specific antibodies to IPSE/alpha-1 and basophils, respectively,
was performed on liver and gut from infected mice. Although
there are differences in the pathology of schistosomiasis between
humans and mice (a. o. due to the difference in host/parasite
size ratio and, thus, the relative worm load), the mouse model
is widely used and accepted as a model for investigation of
immunology of schistosomiasis (63).
Expression of IPSE/alpha-1 correlated with the maturation
stage of the eggs: immature, freshly embolized eggs surrounded
by only few recruited inflammatory cells and intact liver
parenchyma (early granuloma formation) did usually not
yet stain for IPSE/alpha-1, while IPSE/alpha-1 was detected
in larger further developed eggs/granulomas in the typical
subshell location. Secreted IPSE/alpha-1 was detected mainly
in full-blown granulomas in the immediate vicinity of the
eggs. The subshell area of the eggs consists of the von
Lichtenberg’s envelope, which surrounds the miracidium
and contains large amounts of rough endoplasmic reticulum,
and the so-called Reynolds’ Layer, where excretory/secretory
proteins are produced and stored, respectively (23). In the
subshell area also omega-1, another egg-secreted glycoprotein,
which interacts with dendritic cells, has been located
earlier (64).
While the basophil to monocyte ratio of 1:1 in our culture
does not reflect the situation in peripheral blood, where basophils
represent 0.5–1% and monocytes 2–8% of the leukocytes, we
expected that basophils are attracted to and, thus, concentrated in
the egg granulomas. Indeed, immunohistology revealed a striking
enrichment of basophils in the granulomatous lesions, whereas
only few basophils were observed in the residual liver or gut
tissue. Of note: control tissue from non-infected mice was nearly
void of basophils. In small granulomas basophils were detected
close to the eggs, but in large granulomas mainly in the outer
rim of the inflammatory lesions and less frequently near the
eggs. Noteworthy, the antibody used for basophil staining is
directed to mMCP-8, a granule compound of murine basophils
that is released during degranulation. Therefore, we think that
basophils in close vicinity to mature IPSE/alpha-1-secreting eggs
are degranulated upon contact with IPSE/alpha-1 and are, thus,
no longer identified as basophils (ghost cells) with the released
material being eliminated by diffusion and/or degradation.
Nevertheless the question remained, whether basophils
produce enough IL-4 and IL-13 to induce alternative activation
of macrophages. Although Th2 cells are present in much
higher numbers in blood and tissue, basophils release more
IL-4 than Th2 cells on a cellular level (65). Recently, it was
reported that basophils express TLRs, and co-stimulation of
TLR and FcεRI resulted in higher histamine release compared
to FcεRI stimulation alone (66, 67). By RT-PCR and flow
cytometry, we confirmed TLR expression on basophils and found
that the expression patterns varied between individuals. We,
therefore, asked whether TLR activation might likewise enhance
IgE/FcεRI-mediated IL-4 and IL-13 release from basophils.
Indeed simultaneous stimulation by LPS (or the TLR2/6 agonist
FSL-1) boosted the release of IL-4 and IL-13 two- and five-fold,
respectively. This suggests that the high number of basophils
within schistosome egg granulomas together with the boosted
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IL-4 and IL-13 release in the context of TLR activation will
result in a local IL-4 and IL-13 concentration high enough to
induce AAMs.
In conclusion, the results of our study led us to the following
hypothetical model for inflammation control in schistosome
infection: Basophils attracted to schistosome eggs in the gut are
stimulated by both IPSE/alpha-1 via IgE/FcεRI and by bacterial
products via TLR. Combined stimulation boosts basophil
cytokine release to provide local IL-4/IL-13 concentrations
high enough to turn pro-inflammatory monocytes/macrophages
into anti-inflammatory AAMs, thereby ensuring survival of the
hosts.
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